Collaboration to reduce cancer incidence and mortality in Greater Philadelphia
Sidney Kimmel Cancer Center LAPS Institutional Collaboration
The Sidney Kimmel Cancer Center is working to find new ways to prevent and treat cancer, especially for people in the Greater Philadelphia area, so that patients can benefit from better care and innovative treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Thomas Jefferson University NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10590664 on NIH RePORTER |
What this research studies
The Sidney Kimmel Cancer Center aims to decrease cancer incidence and mortality through collaborative research that spans basic, clinical, and population studies. This initiative focuses on addressing the specific cancer-related needs of the Greater Philadelphia area, utilizing a network of hospitals and research facilities. Patients may benefit from innovative treatments and community outreach programs designed to improve cancer care and prevention. The center conducts a wide range of research, from laboratory studies to clinical trials, to ensure that findings are translated into effective patient care.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with cancer or those at high risk for developing cancer within the Greater Philadelphia area.
Not a fit: Patients outside the catchment area or those with non-malignant conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant reductions in cancer incidence and improved treatment options for patients.
How similar studies have performed: Previous research initiatives in similar collaborative cancer centers have shown success in improving patient outcomes and advancing cancer treatment.
Where this research is happening
Philadelphia, United States
- Thomas Jefferson University — Philadelphia, United States (Active)
Researchers
- Principal investigator: Johnson, Jennifer — Thomas Jefferson University
- Study coordinator: Johnson, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.